Breast Cancer

, Volume 26, Issue 4, pp 524–528 | Cite as

Apocrine papillary lesion: comparison of pathological findings from 22 years previously and the present

  • Yuki NomotoEmail author
  • Heiji Yoshinaka
  • Yasuyo Ohi
  • Naoki Hayashi
  • Ayako Nagata
  • Kazunobu Sueyoshi
  • Yuka Eguchi
  • Yoshiaki Shinden
  • Yuko Kijima
  • Shoji Natsugoe
Case Report


Apocrine papillary lesion (APL) is difficult to diagnose as benign or malignant. We experienced an APL remaining in the body for 22 years. We present a case of a 71-year-old woman who had undergone excisional biopsy 22 years previously at the first hospital that she visited. 1 year previously, she had undergone fine-needle aspiration cytology at a second hospital, and the lesion was diagnosed as potentially malignant. She underwent core-needle biopsy at a third hospital, but whether the lesion was benign or malignant could not be definitively diagnosed. We performed right mastectomy and sentinel lymph-node biopsy, because her tumor was suspected to be malignant based on imaging means, and malignancy could not be ruled out on either biopsy or cytology. The histopathological diagnosis was tiny foci of apocrine proliferative lesion with massive hemorrhagic necrosis and no tumor metastasis in two sentinel lymph nodes. Retrospectively, we compared all of the patient’s previous specimens with the present ones, and applied the recent pathological diagnostic criteria. Although the biopsy specimen excised 22 years ago suggested an encapsulated apocrine papillary carcinoma or a papilloma with apocrine ductal carcinoma in situ, neither infiltration nor metastasis has occurred. Furthermore, neither the pathological findings nor the clinical behavior has changed over time.


Apocrine papillary lesion Papilloma with DCIS Encapsulated apocrine papillary carcinoma 


Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest to declare.


  1. 1.
    Mulligan AM, O’Malley FP. Papillary lesions of the breast: a review. Adv Anat Pathol. 2007;14(2):108–19.CrossRefGoogle Scholar
  2. 2.
    Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52(1):20–9.CrossRefGoogle Scholar
  3. 3.
    Ueng SH, Mezzetti T, Tavassoli FA. Papillary neoplasms of the breast: a review. Arch Pathol Lab Med. 2009;133(6):893–907.Google Scholar
  4. 4.
    O’Malley F, Visscher D, MacGrogan G, Tan PH, Ichihara S. Intraductal papilloma. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO classification of tumours of the breast. Lyon: IARC; 2012. pp. 100–5.Google Scholar
  5. 5.
    Peng Y, Butt YM, Zhang X, Tang P. Update on immunohistochemical analysis in breast lesions. Arch Pathol Lab Med. 2017;141:1033–51.CrossRefGoogle Scholar
  6. 6.
    Tramm T, Kim JY, Tavassoli FA. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast. Am J Surg Pathol. 2011;35:202–11.CrossRefGoogle Scholar
  7. 7.
    Hayashi H, Ohtani H, Yamaguchi J, Shimokawa I. A case of intracystic apocrine papillary tumor: diagnostic pitfalls for malignancy. Pathol Res Pract. 2013;209:808–11.CrossRefGoogle Scholar
  8. 8.
    Rakha EA, Ellis IO. Diagnostic challenges in papillary lesions of the breast. Pathology. 2018;50(1):100–10.CrossRefGoogle Scholar
  9. 9.
    Maeda I, Oana Y, Tsugawa K, Takagi M. Availability of immunocytochemistry using cocktail antibody targeting p63/cytokeratin14 for the differential diagnosis of fibroadenoma and ductal carcinoma in situ in fine needle aspiration cytology of the breast. Cytopathology. 2017;28(5):378–384.CrossRefGoogle Scholar
  10. 10.
    Seal M, Wilson C, Naus GJ, Chia S, Bainbridge TC, Hayes MM. Encapsulated apocrine papillary carcinoma of the breast—a tumour of uncertain malignant potential: report of five cases. Virchows Arch. 2009;455:477–83.CrossRefGoogle Scholar
  11. 11.
    Moriya T, Sakamoto K, Sasano H, Kawanaka M, Sonoo H, Manabe T, Ito J. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod Pathol. 2000;13(1):13–8.CrossRefGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2018

Authors and Affiliations

  1. 1.Department of Breast SurgeryKagoshima City HospitalKagoshimaJapan
  2. 2.Department of PathologySagara HospitalKagoshimaJapan
  3. 3.Department of PathologyKagoshima City HospitalKagoshimaJapan
  4. 4.Department of Digestive Surgery, Breast and Thyroid SurgeryKagoshima University HospitalKagoshimaJapan

Personalised recommendations